AeroLeads people directory · profile
Carter Cliff Email & Phone Number
CEO | Director
at
ProTgen Inc
1 work email found
@vascugen.com
2 phones found area 608
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
CEO | Director
Location
United States, United States, United States
Who is Carter Cliff? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Carter Cliff is listed as CEO | Director at ProTgen Inc, based in United States, United States, United States. AeroLeads shows a work email signal at vascugen.com, phone signal with area code 608, and a matched LinkedIn profile for Carter Cliff.
Carter Cliff previously worked as CEO at Papillon Therapeutics Inc and President at Stemcardia. Carter Cliff holds Cell & Molecular Biology from Ut Southwestern Medical Center.
Company email context
Email format at ProTgen Inc
This section adds company-level context without repeating Carter Cliff's masked contact details.
{first_initial}{last}@vascugen.com
86% confidence
AeroLeads found 1 current-domain work email signal for Carter Cliff. Compare company email patterns before reaching out.
Profile bio
About Carter Cliff
Carter Cliff is a CEO | Director at ProTgen Inc. He possess expertise in molecular biology, assay development, immunoassays, cell, biochemistry and 5 more skills.
Listed skills include Molecular Biology, Assay Development, Immunoassays, Cell, and 6 others.
Current workplace
Carter Cliff's current company
Company context helps verify the profile and gives searchers a useful next step.
15 roles · 25 years
Carter Cliff work experience
A career timeline built from the work history available for this profile.
Ceo
CurrentGenetic medicines for multi-systemic treatment of inherited diseases including Cystinosis, Friedreich's ataxia, Danon disease, and Alzheimer's disease.HIGHLIGHT: Papillon's first indication targeting Cystinosis reported positive Ph1/2 data and is now licensed to Novartis.UPDATES: FDA granted both of Papillon's preclinical programs (PPL-001, PPL-002).
Feb 2023 - Present
President
CurrentCellular and genetic medicines to regenerate the heart, including induced pluripotent stem cell (iPSC) cardiomyocyte replacement therapy for treatment of heart failure.HIGHLIGHT: StemCardia licensed over 60 patents from University of Washington (UW) and entered a collaboration with a leading regenerative medicine center University of Southern California.
May 2023 - Present
Co-Founder | Fmr Director
CurrentCellular and genetic medicines to regenerate the brain, including induced pluripotent stem cell (iPSC) dopamine neuron replacement for treatment for Parkinson's disease.HIGHLIGHT: $82 Million Series A Financing co-led by Alaska Permanent Fund Corporation, Cure Ventures and The Column Group, with participation from Euclidean Capital and Saisei Ventures.
Jul 2021 - Present
Co-Founder
CurrentCellular medicines to regenerate the retina, including induced pluripotent stem cell (iPSC) photoreceptor replacement for treatment of inherited primary photoreceptor disease and age-related macular degeneration (AMD).HIGHLIGHT: Opsis entered into a Strategic R&D Alliance with Bayer AG subsidiary, Blue Rock, including a $70 million up-front.
Jul 2016 - Present
Co-Founder | Fmr Director
CurrentCellular medicines to regenerate microvasculature, including induced pluripotent stem cell (iPSC) vascular progenitor replacement as treatment for critical limb threatening ischemia (CLTI/CLI).HIGHLIGHT: Vascugen has completed pre-IND with FDA and manufacture of its clinical grade (GMP) iPSC-derived vascular progenitor product in support of clinical.
Jun 2017 - Present
Co-Founder | Fmr Director
CurrentInclusive clinical pharmacogenetic (PGx) testing, analysis, and reporting of actionable drug compatibility results to patients and leading healthcare providers across the US.HIGHLIGHT: RPRDx operates a dedicated CLIA-certified clinical diagnostic facility offering proprietary Psych HealthPGx Panel and Comprehensive CYP2C19 Test.
Oct 2016 - Present
Co-Founder | Fmr Director
Current
Dianomi Therapeutics
Developed mineral coated microparticle (MCM) platform technology for protein and RNA drugs with improved stability and controlled release.HIGHLIGHT: Entered into a $4 million partnership with Ligand Pharmaceuticals (LGND).
Mar 2017 - Present
Founder | Principal
CurrentFoundry for disruptive biotech ventures with a focus on disease-modifying genetic medicines.
Apr 2016 - Present
Venture Partner
VC fund that combines Western expertise and Japanese innovation to build globally competitive companies that will have the greatest impact on patient lives.HIGHLIGHT: Sasei is one of only nine VC funds certified by the Japan Agency for Medical Research and Development (AMED), who provide matching investment from the Japanese government.
Jun 2021 - Dec 2023
Director Of Business Development
Jun 2010 - Mar 2016
Field Sales Executive
Nov 2005 - Jun 2010
Field Application Scientist
2003 - 2005
~2 yrs
Scientific Advisor
Ingenuity Systems
2001 - 2004
~3 yrs
Field Sales Executive
2001 - 2003
~2 yrs
3 education records
Carter Cliff education
Cell & Molecular Biology
Ut Southwestern Medical Center
Molecular Biology
The University Of Texas At Austin
Dual B.S., Chemistry & Biology
New Mexico Institute Of Mining And Technology
FAQ
Frequently asked questions about Carter Cliff
Quick answers generated from the profile data available on this page.
What company does Carter Cliff work for?
Carter Cliff works for ProTgen Inc.
What is Carter Cliff's role at ProTgen Inc?
Carter Cliff is listed as CEO | Director at ProTgen Inc.
What is Carter Cliff's email address?
AeroLeads has found 1 work email signal at @vascugen.com for Carter Cliff at ProTgen Inc.
What is Carter Cliff's phone number?
AeroLeads has found 2 phone signal(s) with area code 608 for Carter Cliff at ProTgen Inc.
Where is Carter Cliff based?
Carter Cliff is based in United States, United States, United States while working with ProTgen Inc.
What companies has Carter Cliff worked for?
Carter Cliff has worked for Protgen Inc, Papillon Therapeutics Inc, Stemcardia, Kenai Therapeutics, and Opsis Therapeutics.
How can I contact Carter Cliff?
You can use AeroLeads to view verified contact signals for Carter Cliff at ProTgen Inc, including work email, phone, and LinkedIn data when available.
What schools did Carter Cliff attend?
Carter Cliff holds Cell & Molecular Biology from Ut Southwestern Medical Center.
What skills is Carter Cliff known for?
Carter Cliff is listed with skills including Molecular Biology, Assay Development, Immunoassays, Cell, Biochemistry, Biotechnology, Life Sciences, and Cell Culture.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial